東吳證券(601555.SH):一季度淨利同比預增100%至120%
格隆匯4月8日丨東吳證券(601555.SH)公佈2025年第一季度業績預增公告,公司預計2025年第一季度實現歸屬於母公司所有者的淨利潤9.12億元至10.03億元,同比增加100%至120%。預計公司2025年第一季度實現歸屬於母公司所有者的扣除非經常性損益的淨利潤8.92億元至9.81億元,同比增加100%至120%。
2025年第一季度,公司主動應對複雜嚴峻的外部環境,積極把握市場機遇,堅持穩字當頭、穩中求進,強化合規風控管理,堅持走好特色化發展之路,紮實推進高質量發展,實現經營業績持續提升,財富管理、投資交易等多項業務穩步增長,歸屬於母公司所有者的淨利潤預計同比增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.